Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Restructuring Costs (2019 - 2026)

Healthequity has reported Restructuring Costs over the past 8 years, most recently at $1.3 million for Q1 2026.

  • Quarterly results put Restructuring Costs at $1.3 million for Q1 2026, down 39.21% from a year ago — trailing twelve months through Jan 2026 was $5.0 million (down 87.61% YoY), and the annual figure for FY2026 was $5.0 million, down 87.61%.
  • Restructuring Costs for Q1 2026 was $1.3 million at Healthequity, up from $1.2 million in the prior quarter.
  • Over the last five years, Restructuring Costs for HQY hit a ceiling of $34.4 million in Q4 2024 and a floor of $1.2 million in Q4 2025.
  • Median Restructuring Costs over the past 5 years was $2.3 million (2024), compared with a mean of $6.5 million.
  • Biggest five-year swings in Restructuring Costs: skyrocketed 1197.06% in 2024 and later plummeted 96.63% in 2025.
  • Healthequity's Restructuring Costs stood at $6.5 million in 2022, then crashed by 59.21% to $2.7 million in 2023, then skyrocketed by 1197.06% to $34.4 million in 2024, then plummeted by 96.63% to $1.2 million in 2025, then increased by 14.24% to $1.3 million in 2026.
  • The last three reported values for Restructuring Costs were $1.3 million (Q1 2026), $1.2 million (Q4 2025), and $1.3 million (Q3 2025) per Business Quant data.